🕵️ Enovis Corp ($ENOV)
SEC insider & ownership activity, last 12 months · CIK 1420800 · every row links its SEC filing
Over the last 12 months insiders sold $45K against $762K of open-market buying. Engert Oliver bought $438K (Feb–Sep). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
3 buyers, $762K (18 lots) · 1 seller, $45K (4 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Engert Oliver | 16 | $438K | 0 | – | Sep 4, 2026 |
| McDonald Damien | 1 | $250K | 0 | – | Sep 4, 2026 |
| Kleckner John | 1 | $75K | 0 | – | Nov 25, 2025 |
| Daniel A. Pryor | 0 | – | 4 | $45K | Dec 9, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 16.0% | 13G | Jul 28, 2026 | filing ↗ | |
| American Century Investment Management, Inc. | 10.6% | 13G | Jul 8, 2026 | filing ↗ | |
| American Century Companies, Inc. | 10.6% | 13G | Jul 8, 2026 | filing ↗ | |
| Stowers Institute for Medical Research | 10.6% | 13G | Jul 8, 2026 | filing ↗ | |
| Vanguard Portfolio Management | 6.8% | 13G | Apr 29, 2026 | filing ↗ | |
| Rubric Capital Management LP | 6.8% | 13G | Aug 14, 2026 | filing ↗ | |
| David Rosen | 6.8% | 13G | Aug 14, 2026 | filing ↗ | |
| Vanguard Capital Management | 5.2% | 13G | Apr 29, 2026 | filing ↗ | |
| Diamond Hill Capital Management Inc | 5.0% | 13G | Feb 6, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Aug 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 31, 2026 | filing ↗ |
| Earnings (2.02) | Aug 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 6, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 19, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 19, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Earnings (2.02) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 10, 2025 | filing ↗ |
| Material agreement (1.01) | Dec 8, 2025 | filing ↗ |
| New financial obligation (2.03) | Dec 8, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 8, 2025 | filing ↗ |
| Officer/director changes (5.02) | Nov 7, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |